These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 197724)

  • 21. Dissociable properties of dopamine neurons im the nigrostriatal and mesolimbic dopamine systems.
    Koob GF; Del Fiacco M; Iversen SD
    Adv Biochem Psychopharmacol; 1977; 16():589-95. PubMed ID: 560793
    [No Abstract]   [Full Text] [Related]  

  • 22. [The problem of localizing brain functions].
    Kukuev LA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1974; 74(5):769-75. PubMed ID: 4616594
    [No Abstract]   [Full Text] [Related]  

  • 23. The neuroleptics. 2. Neurophysiology and neuropharmacology.
    Albe-Fessard D; Bradley PB; Gerschenfeld HM; Herz A; Krnjević K; Lodin Z; Marczynski TJ; Massion J; Meulders M; Poirier LJ; Salmoiraghi GC; Schlag J; Tauc L; Wall PD
    Mod Probl Pharmacopsychiatry; 1970; 5():12-22. PubMed ID: 4348144
    [No Abstract]   [Full Text] [Related]  

  • 24. R-(-)-deprenyl (Selegiline, Movergan) facilitates the activity of the nigrostriatal dopaminergic neuron.
    Knoll J
    J Neural Transm Suppl; 1987; 25():45-66. PubMed ID: 2828537
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Striatal and limbic dopamine function: evidence from animal studies.
    Alpert JE; Iversen SD
    Ann Neurol; 1983 May; 13(5):578. PubMed ID: 6683480
    [No Abstract]   [Full Text] [Related]  

  • 26. Multiple parallel memory systems in the brain of the rat.
    White NM; McDonald RJ
    Neurobiol Learn Mem; 2002 Mar; 77(2):125-84. PubMed ID: 11848717
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of 4-chlorophenoxyamphetamine (A-6587), d-amphetamine and 4-chloroamphetamine on brain biogenic amines and behavior in mice.
    Everett GM; Yellin TO
    Res Commun Chem Pathol Pharmacol; 1971; 2(4):407-13. PubMed ID: 4400361
    [No Abstract]   [Full Text] [Related]  

  • 28. Clinical and laboratory studies with selective monoamine-oxidase-inhibiting drugs. Implications for hypothesized neurotransmitter changes associated with depression and antidepressant drug effects.
    Murphy DL; Cohen RM; Siever LJ; Roy B; Karoum F; Wyatt RJ; Garrick NA; Linnoila M
    Mod Probl Pharmacopsychiatry; 1983; 19():287-303. PubMed ID: 6408411
    [No Abstract]   [Full Text] [Related]  

  • 29. [Concentration of monoamines in the brain of minks differing in their reaction to man].
    Nikulina EM; Trapezov OV; Popova NK
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1985; 35(6):1142-6. PubMed ID: 2418599
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Biogenic monoamines and convulsion potential of the brain].
    Vediaev FP; Sergienko NG
    Usp Fiziol Nauk; 1984; 15(1):55-75. PubMed ID: 6322467
    [No Abstract]   [Full Text] [Related]  

  • 31. From arousal to cognition: the integrative position of the prefrontal cortex.
    Robbins TW
    Prog Brain Res; 2000; 126():469-83. PubMed ID: 11105663
    [No Abstract]   [Full Text] [Related]  

  • 32. [Relationship between the rate of extinction of an avoidance reaction in rats and the concentration of noradrenaline in the brain].
    Saul'skaia NB; Suvorov VV
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1979; 29(1):185-7. PubMed ID: 433441
    [No Abstract]   [Full Text] [Related]  

  • 33. [Correlation between rate of avoidance reaction elaboration and catecholamine levels in rat brain].
    Saul'skaia NB
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1979; 29(4):731-6. PubMed ID: 484030
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Monoamine and monoamine enzyme abnormalities in childhood autism].
    Garnier C; Barthelemy C; Garreau B; Jouve J; Muh JP; Lelord G
    Encephale; 1983; 9(3):201-62. PubMed ID: 6317336
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The monoamine oxidases of brain: selective inhibition with drugs and the consequences for the metabolism of the biogenic amines.
    Yang HY; Neff NH
    J Pharmacol Exp Ther; 1974 Jun; 189(3):733-40. PubMed ID: 4843170
    [No Abstract]   [Full Text] [Related]  

  • 36. Turning in circles: the neuropharmacology of rotation.
    Glick SD; Jerussi TP; Fleisher LN
    Life Sci; 1976 May; 18(9):889-96. PubMed ID: 775231
    [No Abstract]   [Full Text] [Related]  

  • 37. The role of brain catecholamines in the regulation of ACTH secretion.
    Van Loon GR
    Adv Neurol; 1974; 5():479-86. PubMed ID: 4374068
    [No Abstract]   [Full Text] [Related]  

  • 38. Constraints on inferring neurochemical involvement in behavior.
    Dismukes RK
    Neurosci Res Program Bull; 1978 Dec; 16(4):580-4. PubMed ID: 35765
    [No Abstract]   [Full Text] [Related]  

  • 39. [Stereotyped movements and substantia nigra-corpus striatum dopaminergic function in the rat: action of methylphenidate after inhibition of monoamine oxidase].
    Duteil J; de Sereville JE; Multon MF; Pessonnier J; Rambert FA
    Ann Pharm Fr; 1987; 45(1):25-34. PubMed ID: 3662339
    [No Abstract]   [Full Text] [Related]  

  • 40. [Characteristics and functions of intraneuronal compartments of monoamines in the central nervous system].
    Gowinski J; Besson MJ; Cheramy A; Javoy F; Thierry AM
    Rev Neurol (Paris); 1972 Jul; 127(1):1-22. PubMed ID: 4677511
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.